Butadiene telomerization catalyst precursor preparation
US-2016271601-A1 · Sep 22, 2016 · US
US10751706B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10751706-B2 |
| Application number | US-202016741987-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 14, 2020 |
| Priority date | Dec 13, 2013 |
| Publication date | Aug 25, 2020 |
| Grant date | Aug 25, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Use a solvent blend that contains 1-methoxy-2,7-octadiene and an alkanols rather than the alkanols by itself to prepare a catalyst precursor suitable for use in butadiene telomerization.
Opening claim text (preview).
What is claimed is: 1. A process for preparing a telomerization catalyst precursor used in telomerization of butadiene that comprises dissolving one equivalent of palladium acetyl acetonate and from one to three equivalents of a tertiary phosphine ligand in a solvent that comprises methanol and, optionally, 1-methoxy-2,7-octadiene at a temperature within a range of from 0 degrees centigrade to 100 degrees centigrade to yield a catalyst precursor solution wherein the tertiary phosphine ligand is represented formulaically as R 1 PR 2 and where R 1 is an aryl group or a substituted aryl group or an alkyl group or heteroatom-containing alkyl group with 1 to 12 carbon atoms, and R 2 is independently a heterocyclic oxaadamantyl group. 2. The process of claim 1 wherein the phosphine-containing heterocyclic oxaadamantyl groups is represented schematically as shown below: 3. The process of claim 2 wherein the heterocyclic oxaadamantyl ligand is 1,3,5,7-tetramethyl-6-phenyl-2,4,8-trioxa-6-phosphaadamantane (TMPTPA) or 1,3,5,7-tetramethyl-6-(2-methoxyphenyl)-2,4,8-trioxa-6-phosphaadamantane (TMPTPA-OMe). 4. The process of claim 1 , wherein the conditions include a temperature within a range of from 5 degrees centigrade to 60 degrees centigrade. 5. The process of claim 1 , wherein the number of equivalents of a tertiary phosphine ligand is one or two. 6. The process of claim 1 , wherein the solvent comprises 1-methoxy-2,7-octadiene. 7. The process of claim 6 , wherein the solvent has a 1-methoxy-2,7-octadiene content within a range of from 0.1 weight percent to 50 weight percent, based upon total solvent blend weight. 8. The process of claim 6 , wherein the solvent has a 1-methoxy-2,7-octadiene content within a range of from 10 weight percent to 25 weight percent, based upon total solvent blend weight. 9. The process of claim 1 , wherein the catalyst precursor solution has a palladium concentration that ranges from 0.02 weight percent to 2 weight percent, as palladium metal, based on total catalyst precursor solution weight. 10. The process of claim 1 , wherein the catalyst precursor solution has a palladium concentration that ranges from 0.1 weight percent to 1 weight percent, as palladium metal, based on total catalyst precursor solution weight. 11. The process of claim 1 , wherein the telomerization catalyst precursor remains in solution for a period of at least 360 hours at a temperature within a range of from 5° C. to 60° C. and a palladium concentration exceeding 0.1 weight percent.
Palladium compounds · CPC title
Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring · CPC title
Complexes comprising multidentate ligands, i.e. more than 2 ionic or coordinative bonds from the central metal to the ligand, the latter having at least two donor atoms, e.g. N, O, S, P · CPC title
Palladium · CPC title
and further hetero atoms as ring members, excluding the positions adjacent to P · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.